BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27259651)

  • 1. Factors Affecting Quality of Life at Different Intervals After Treatment of Localized Prostate Cancer: Unique Influence of Treatment Decision Making Satisfaction, Personality and Sexual Functioning.
    Victorson DE; Schuette S; Schalet BD; Kundu SD; Helfand BT; Novakovic K; Sufrin N; McGuire M; Brendler C
    J Urol; 2016 Nov; 196(5):1422-1428. PubMed ID: 27259651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.
    Goh AC; Kowalkowski MA; Bailey DE; Kazer MW; Knight SJ; Latini DM
    BJU Int; 2012 Jul; 110(2 Pt 2):E50-6. PubMed ID: 22145791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric Evaluation of PROMIS Sexual Function and Satisfaction Measures in a Longitudinal Population-Based Cohort of Men With Localized Prostate Cancer.
    Reeve BB; Wang M; Weinfurt K; Flynn KE; Usinger DS; Chen RC
    J Sex Med; 2018 Dec; 15(12):1792-1810. PubMed ID: 30539735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.
    Orom H; Biddle C; Underwood W; Nelson CJ; Homish DL
    Med Decis Making; 2016 Aug; 36(6):714-25. PubMed ID: 26957566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiety and distress during active surveillance for early prostate cancer.
    van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
    Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life.
    Lane A; Metcalfe C; Young GJ; Peters TJ; Blazeby J; Avery KN; Dedman D; Down L; Mason MD; Neal DE; Hamdy FC; Donovan JL;
    BJU Int; 2016 Dec; 118(6):869-879. PubMed ID: 27415448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personality predicts prostate cancer treatment decision-making difficulty and satisfaction.
    Orom H; Penner LA; West BT; Downs TM; Rayford W; Underwood W
    Psychooncology; 2009 Mar; 18(3):290-9. PubMed ID: 18821530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of prostate cancer diagnosis and treatment decision-making on health-related quality of life before treatment onset.
    Cuypers M; Lamers RED; Cornel EB; van de Poll-Franse LV; de Vries M; Kil PJM
    Support Care Cancer; 2018 Apr; 26(4):1297-1304. PubMed ID: 29127529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personality, treatment choice and satisfaction in patients with localized prostate cancer.
    Block CA; Erickson B; Carney-Doebbling C; Gordon S; Fallon B; Konety BR
    Int J Urol; 2007 Nov; 14(11):1013-8. PubMed ID: 17956529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
    Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
    Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of sexual satisfaction in men with prostate cancer.
    Nelson CJ; Choi JM; Mulhall JP; Roth AJ
    J Sex Med; 2007 Sep; 4(5):1422-7. PubMed ID: 17634054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life, sexual function and decisional regret at 1 year after surgical treatment for localized prostate cancer.
    Davison BJ; So AI; Goldenberg SL
    BJU Int; 2007 Oct; 100(4):780-5. PubMed ID: 17578466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defining sexual outcomes after treatment for localized prostate carcinoma.
    Schover LR; Fouladi RT; Warneke CL; Neese L; Klein EA; Zippe C; Kupelian PA
    Cancer; 2002 Oct; 95(8):1773-85. PubMed ID: 12365027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients' perceptions of quality of life after treatment for early prostate cancer.
    Clark JA; Inui TS; Silliman RA; Bokhour BG; Krasnow SH; Robinson RA; Spaulding M; Talcott JA
    J Clin Oncol; 2003 Oct; 21(20):3777-84. PubMed ID: 14551296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer.
    Tavlarides AM; Ames SC; Diehl NN; Joseph RW; Castle EP; Thiel DD; Broderick GA; Parker AS
    Psychooncology; 2013 Jun; 22(6):1328-35. PubMed ID: 22855322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors Affecting Satisfaction with the Decision-Making Process and Decision Regret for Men with a New Diagnosis of Prostate Cancer.
    Skyring TA; Mansfield KJ; Mullan JR
    Am J Mens Health; 2021; 15(4):15579883211026812. PubMed ID: 34261353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is quality of life different for men with erectile dysfunction and prostate cancer compared to men with erectile dysfunction due to other causes? Results from the ExCEED data base.
    Penson DF; Latini DM; Lubeck DP; Wallace K; Henning JM; Lue T
    J Urol; 2003 Apr; 169(4):1458-61. PubMed ID: 12629383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry.
    Cuypers M; Lamers RED; de Vries M; Husson O; Kil PJM; van de Poll-Franse LV
    Urol Oncol; 2016 Nov; 34(11):482.e11-482.e18. PubMed ID: 27432432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of forecasted assessment of quality of life to validate time-trade-off utilities and a prostate cancer screening decision-analytic model.
    Cantor SB; Deshmukh AA; Krahn MD; Volk RJ
    Health Expect; 2015 Oct; 18(5):1610-20. PubMed ID: 26039695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.